Metformin Black / African Ancestry Dose Adjustments
Evidence-based guide to metformin dosing, pharmacogenomics, and clinical considerations for patients of Black or African ancestry, including G6PD, OCT2, and CKD context.
Read clinical reviewTopic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.

Explore
Showing 6 of 6 clinical reviews.
Evidence-based guide to metformin dosing, pharmacogenomics, and clinical considerations for patients of Black or African ancestry, including G6PD, OCT2, and CKD context.
Read clinical reviewA clinician-reviewed guide to how metformin pharmacokinetics, pharmacogenomics, dosing thresholds, and adverse-effect risks differ in East Asian patients, with ethnicity-stratified trial data and prescribing guidance.
Read clinical reviewA clinician-reviewed guide to metformin dosing in Hispanic and Latino patients, covering pharmacogenomics, diabetes prevalence, ethnicity-stratified trial data, and practical dose titration protocols.
Read clinical reviewA clinical deep-dive into metformin pharmacogenomics, pharmacokinetics, and outcomes data specific to Black and African ancestry populations, including OCT1/OCT2 variants, renal considerations, and dosing guidance.
Read clinical reviewSouth Asian patients develop type 2 diabetes a decade earlier and at lower BMI than European patients. This guide covers metformin dosing, pharmacogenomics, and clinical protocols specifically for South Asian individuals, with evidence from major trials and ethnicity-stratified data.
Read clinical reviewA clinician-reviewed guide to how metformin's safety profile, pharmacogenomics, and optimal dosing differ for South Asian patients, with ethnicity-stratified trial data, PharmGKB findings, and practical prescribing guidance.
Read clinical review